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Abstract 
Introduction: The nuclear factor kappa B is one of the most promising targets for the 
development of innovative medicines in the development of modern pharmacology and the 
formation of the concept of targeted therapy. Potential candidates modulating the activity of this 
transcription factor are 3-hydroxypyridine derivatives. 
Materials and methods: At the first stage of our study, 11 pharmacological agents-inhibitors of 
NF-κB in vitro were screened with an estimate of the activity of the p65 subunit in mononuclear 
cells stimulated by bacterial lipopolysaccharide. The most active substances were: mexidol, 
ethoxidol and the agent under the code XS-9. Further inhibitory activity against NF-κB 
pharmacological agents was studied on 4 models: L-NAME-induced endothelial dysfunction, 
staphylococcal sepsis, acute toxic liver damage and acute pancreatitis. 
Main part: On L-NAME-induced endothelial dysfunction, the inhibitory activity of the 
compounds, was arranged in the following order: XS-9 → ethoxydol → mexidol. With 
staphylococcal sepsis and acute toxic liver damage, the compounds XS-9 and ethoxidol 
demonstrated the same effectiveness with respect to the modulation of the activity of the NF-κB 
signaling system, mexidol had the least effect. On the model of acute pancreatitis, the inhibitory 
activity of the compounds, was arranged in the following order: ethoxidol → XS-9 → mexidol. 
Conclusion: Thus, 3-hydroxypyridine derivatives showed a significant activity on the NF-κB 
signaling system, both in the screening method and in various models leading to its pathological 
activation. In this connection, it is necessary to study further the mechanisms of action of these 
pharmacological substances and to confirm their effectiveness in the presented models in in vivo 
experiments. 
Key words: Nuclear factor kappa B; NF-κB, 3-hydroxypyridine derivatives; pharmacological 
correction. 
Introduction. 
The derivatives of 3-hydroxypyridine belong to 
the simplest heterocyclic analogues of aromatic 
phenols and have a wide spectrum of 
pharmacological activity: antioxidant, antihypoxic, 
anti-inflammatory and anti-ischemic [1], cardio- and 
endothelioprotective [2, 3], antistress, 
neuroprotective [1] and  many others. An extensive 
list of the types of pharmacological effects can be 
explained by the involvement of the signaling system 
of the transcription factor, the kappa B factor, in the 
implementation of these protective processes. In this 
connection, the confirmation of the hypothesis of the 
presence of potential inhibitory NF-κB activity in 3-
hydroxypyridine derivatives is an important stage in 
the development of a new class of medicinal means 
with antioxidant properties [3, 4, 5]. It was  decided 
to conduct a screening study so as to select the most 
effective 3-hydroxypyridine derivatives on 
mononuclear cells of intact rats [6] and further study 
their inhibitory effect on the NF-κB signaling system 
in various models.     
Rus. 
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Materials and methods. 
For the purpose of screening for NF-κB 
inhibitors, we studied a number of drugs that were 
added to freshly isolated standard ficoll density 
gradient (ρ = 1.077, PANECO, Russia) mononuclear 
cells (MNCs) of blood of 6 intact Wistar rats, 3 males 
and 3 females. 
The preparations used in the screening study at 
the final concentrations are presented in Table 1. 
Table 1 
Characteristics of the studied drugs 
Name Chemical name 
The in vitro 
concentration, 
μg / ml 
Mexidol 
2-ethyl-6-methyl-3-
hydroxypyridine succinate 
35 
Ethoxydol 
2-Ethyl-6-methyl-3-
hydroxypyridine malate 
35 
LHT-05-
09 
3-hydroxy-2-ethyl-6-
methylpyridinium glutamate 
35 
LHT-20-
16 
3-hydroxy-2-ethyl-6-
methylpyridinium 
asparaginate 
35 
LHT-03-
15 
3-hydroxy-2-ethyl-6-
methylpyridinium 4-
aminobenzoate 
35 
LHT-21-
16 
3-hydroxy-2-ethyl-6-
methylpyridinium nicotinate 
35 
LHT-01-
09 
3-hydroxy-2-ethyl-6-
methylpyridinium N-
acetylaminohexanoate 
35 
LHT-4-97 
3-hydroxy-2-ethyl-6-
methylpyridinium N-
acetylaminoacetate 
35 
LHT-02-
09 
3-hydroxy-2-ethyl-6-
methylpyridinium N-
acetylaminoglutamate 
35 
LHT-11-
09 
3-hydroxy-2-ethyl-6-
methylpyridinium 
acetylsalicylate 
35 
XS-9 
Beta-
hydroxynicotinoylhydrazone 
2-methyl-3-hydroxy-4-
formyl-5-
hydroxymethylpyridine 
dihydrochloride 
35 
Screened preparations were further tested at the 
same concentrations on the MNCs blood of Wistar 
rats with L-NAME-induced endothelial dysfunction, 
staphylococcal sepsis, acute toxic liver damage and 
acute pancreatitis (6 animals in each subgroup, 3 
males and 3 females). 
L-NAME induced endothelial dysfunction was 
modeled by administration of NG-nitro-L-arginine 
methyl ester (L-NAME) to rats according to the 
conventional method [7, 8]. Blood sampling for a 5 
ml study was carefully performed with aseptic and 
antiseptic drugs from the right ventricle of the heart 
on the 8th day. 
Staphylococcal sepsis was modeled using 
Staphylococcus aureus culture as described 
previously [9]. Blood sampling for a 5 ml study was 
carefully performed with aseptic and antiseptic drugs 
from the right ventricle of the heart on the 3rd day. 
Acute toxic liver damage was modeled by 
intraperitoneal injection of 3 ml / kg carbon 
tetrachloride as a 50% solution in olive oil, three 
times, after 24 hours. Blood sampling for a 5 ml 
study with careful observance of aseptic and 
antiseptic was performed from the right ventricle of 
the heart on the 4th day. 
Acute pancreatitis was modeled by R.N. Wang 
in the modification of S.A. Alekhin [10]. Blood 
sampling for 5 ml was carefully performed with 
aseptic and antiseptic drugs from the right ventricle 
of the heart on the  5th day. 
The NF-κB activity was studied in 2 ml eppendorf 
tubes (Gen Follower, China), where 1 ml of the rat 
MNC  slurry, 1 × 106 cells per ml of RPMI-1640 
medium (Paneco, Russia) was added with 5% serum  of 
embryos of cows (HiClone, USA), then the test 
preparation dissolved in phosphate-buffered saline was 
added at the appropriate final concentration, in a 
screening experiment – bacterial lipopolysaccharide 
(Pyrogenal, NF Gamalei Institute, Russia) in 
concentration 1 μg / ml. The cells were incubated for 30 
minutes at 37 ° C on a shaker, then centrifuged for 5 
minutes at 200 g, after that  the supernatant  was  
removed, the MNC pellet was examined for p65 
activity of the NF-κB subunit in strict accordance with 
the instructions for the NFkB p65 kit. TotalMultispecies 
InstantOne ™ ELISA Kit Invitrogen / Thermo Fisher 
Scientific, cat., 85-86081-11). 
Briefly, the rat MNCs of 1 × 106 rats was lysed in 
1 ml of the lysis buffer included in the kit, the 
supernatant was added to the wells of a 96-well plate 
from the ELISA kit. After several steps, the sandwich 
reaction products were determined on a Multiskan FC 
microplate reader (Thermo Fisher, Germany) at 
450 nm. 
Since there are no conventional units of NF-κB 
activity, and the chosen research method allows to 
determine the quantitative content of the p65 subunit 
of NF-κB in an arbitrary number of cells (in our case, 
1 × 106 MNCs) in order to simplify further 
calculations of the relative effect of the studied 
substances, units of optical density, directly obtained 
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from a microplate reader, rounded to the 2nd decimal 
place. The statistical processing of the results was 
carried out in the MS Excel 2013 program with the 
Attestatv.13 module using the non-parametric 
statistics method – Kruskal-Wallis criterion- as the 
distribution of the p65 subunit of NF-κB in the cells 
was not normal. 
Main part. 
The results of the screening of candidates for the 
role of inhibitors of NF-κB activity (Medians – Me 
and 1, 3 quartiles – Q1; Q3) are presented in Table 2 
and in Fig. 1. 
Table 2 
The result of a screening study of theinhibitory NF-κB activity of various 3-hydroxypyridine derivatives 
Group 
Me Q1; Q3 
Group 
Me Q1; Q3 
Unit of optical density Unit of optical density 
Intact 0.17 0.16; 0.18 LHT-21-16 1.05 1.02; 1.09 
Control of LPS 2.22 1.79; 2.46 LHT-01-09 0.95 0.92; 0.99 
Mexidol 0.78 0.68; 0.93 LHT-4-97 1.93 1.87; 1.97 
Ethoxydol 0.79 0.68; 0.92 LHT-02-09 1.51 1.48; 1.55 
LHT-05-09 2.01 1.95; 2.07 LHT-11-09 0.83 0.81; 0.86 
LHT-20-16 0.80 0.78; 0.85 XS-9 0.65 0.62; 0.73 
LHT-03-15 1.14 1.11; 1.18 
Fig. 1. Effect of the study drugs on LPS-induced NF-κB activity in mononuclear cells of intact rats 
As can be seen from Fig. 1, mexidol, ethoxydol 
and XS-9 were the most inhibitory in the LPS-
induced expression of p65 NF-κB in MNCs. 
Therefore, these substances were chosen for further 
studies in experimental models.  
One possible pathology, where inhibition of NF-
κB activity is pathogenetically justified, the solution 
of which will reduce the stimulating effect of the 
produced pro-inflammatory cytokines on the 
endothelium, is endothelial dysfunction. To study the 
inhibitory potential of the drugs studied, the latter 
was chosen in the model of chronic vascular 
pathology, reproduced by L-NAME induction as well  
as  in the variant of acute dysfunction inherent in 
septic shock and reproduced by the introduction of 
endotoxin and live staphylococcus.  
The results are shown in Fig. 2 and 3. 
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Fig. 2. Effect of the study drugs on the activity of NF-κB in mononuclear blood cells 
of rats with L-NAME-induced endothelial dysfunction. 
Note: * – p <0.05 compared with the control 
Fig. 3. Effect of the study drugs on the activity of NF-κB in mononuclear blood cells of rats with staphylococcal sepsis. 
Note: * – p <0.05 compared with the control 
 As can be seen from the data obtained, all 3 of the 
studied drugs significantly decreased the NF-κB activity 
in the rat MNCs  with both types of experimental 
endothelial dysfunction, although the severity of the 
inhibitory capacity depended on the degree of initial 
activity: in the septic process, NF-κB activity under the 
influence of ethoxydol and XS-9 decreased more than 
2-fold, and in the case of L-NAME-induced endothelial 
dysfunction, this decrease was less pronounced, and 
there was also a tendency for greater inhibitory activity 
of these two drugs, not reaching the  reliable difference 
with mexidol. 
The inhibitory effect of ethoxidol and XS-9 on 
NF-κB activity was significantly higher in 
comparison with mexidol in MNCs obtained in 
animals with experimental hepatitis  where these two 
drugs significantly suppressed NF-κB, while mexidol 
did not exert any actions.  
On the model of acute toxic damage of the liver 
we observed the smallest increase in the activity of 
NF-κB in the MNCs of animals as compared to other 
models, and ethoxydol and XS-9 returned this 
activity to the norm observed in intact animals. 
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Fig. 4. Influence of the study drugs on the activity of NF-κB in mononuclear blood cells of rats with acute toxic liver damage. 
Note: * – p <0.05 compared with the control; ** – p <0.05 in comparison with mexidol 
Acute experimental pancreatitis is accompanied 
by severe systemic inflammation, which is naturally 
reflected in a significant increase in the activity of 
NF-κB in the rat MNCs (Figure 5). All the drugs, 
studied by us, suppressed the activity of this factor, 
but with varying degrees of severity. Reducing the 
concentration of p65 NF-κB under the influence of 
mexidol did not reach statistical significance at all, 
while ethoxidol had a significantly more pronounced 
effect not only in comparison with mexidol  but also 
in comparison with XS-9. 
Fig. 5. Effect of  the  study drugs on the activity of NF-κB in mononuclear blood cells of rats with experimental pancreatitis. 
Note: * – p <0.05 compared with the control; ** – p <0.05 in comparison with mexidol and XS-9. 
In Table 3  all  the experiments  are  summarized. 
Table 3 
The optical density in all experiments is median; 1st and 3rd quartiles 
Group 
L-NAME Sepsis ATLD Pancreatitis 
Me Q1; Q3 Me Q1; Q3 Me Q1; Q3 Me Q1; Q3 
Intact 0.17 0.14; 0.17 0.17 0.16; 0.21 0.15 0.09; 0.17 0.17 0.10; 0.17 
Control 0.35 0.32; 0.38 1.67 1.48; 1.81 0.27 0.21; 0.37 1.23 1.20; 1.27 
Mexidol 0.26 0.21; 0.28 1.06 1.02; 1.09 0.26 0.25; 0.26 0.97 0.94; 1.00 
Ethoxydol 0.21 0.19; 0.23 0.77 0.74; 0.79 0.16 0.15; 0.20 0.51 0.45; 0.58 
XS-9 0.19 0.18; 0.21 0.79 0.77; 0.83 0.17 0.16; 0.17 0.80 0.73; 0.82 
Note:  ATLD – acute toxic liver damage 
Discussion. The family of the transcription factor 
NF-κB plays an important role in the life cycle of the 
cell, regulating the processes of proliferation, apoptosis, 
inflammation, cell migration, angiogenesis, immune 
response and others [11, 12, 13, 14]. On the other hand, 
the NF-κB signal system with inadequate stimulation 
leads to the formation of vicious circles and key 
pathogenetic links in the development of cardiovascular 
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diseases  including endothelial dysfunction [15, 16], 
liver diseases [17, 18], pancreas [19 , 20], oncological 
diseases [21, 22] and comorbidity. 
Thus, some potential target genes under the 
transcriptional control of NF-κB contribute to the 
development of endothelial dysfunction of the 
"proatherogenic" phenotype. These genes encode the 
synthesis of such pro-inflammatory molecules as 
interleukin-6, tumor necrosis factor α, the receptor 
for the final glycosylation products (RAGE) [13, 14]. 
This, in turn, activates chemotaxis, adhesion and 
oxidative stress, supports chronic inflammation and 
endothelial dysfunction. 
Both normal and pathological conditions, 
activation of NF-κB can be carried out in two ways: 
canonical and noncanonical [23, 24]. The canonical 
pathway of activation is triggered by the action of 
tumor necrosis factor-α, interleukin-1β, or ligands of 
Toll-like receptors of various types (eg, bacterial 
lipopolysaccharides). The non-canonical pathway is 
realized through the receptors of the TNF family, 
including the receptor of a factor activating B-
lymphocytes and a CD40 ligand [24]. 
In unstimulated cells the nuclear factor Kappa B 
dimers are combined in the cytoplasm with inhibitory 
proteins – IκBs. Stimulus-mediated activation of IκB 
kinase leads to the degradation of IκBs for the release 
and activation of NF-κB [25]. The family of 
inhibitory proteins include IκBα, IκBβ, IκBγ / р105, 
IκBδ / р100, IκBε and factor-3 B-cell lymphoma 
(Bcl-3).  They all consist of 30-33 amino acids that 
bind to NF-κB, which preserves this factor in the 
cytoplasm [11]. When the signaling pathway is 
activated, IκBs undergo phosphorylation and 
ubiquitinization. The best studied is IκBα. 
Stimulation of cells leads to its phosphorylation and 
binding of ubiquitin, which causes proteolysis in the 
system of the 26S-proteasome complex and results in 
the release of NF-κB, which after additional 
phosphorylation is allowed to migrate to the site of 
its action-into the nucleus of the cell. Transcriptional 
activity of NF-κB appears within a few minutes after 
stimulation [11, 25]. That is, the degradation of IκBα 
alters the balance between cytoplasmic and nuclear 
localization of NF-κB in favor of the latter, which 
allows dimers to accumulate in the nucleus and 
activate gene transcription. IκBα itself, which can 
penetrate the nucleus, displaces NF-κB from the 
DNA bond  and transports it back to the cytoplasm, 
realizing the principle of negative feedback [23]. 
One of the pathological links caused by 
stimulation-mediated activation of NF-κB is the 
formation of chronic inflammation of low gradation – a 
typical, multi-syndrome, pathological process that 
develops during systemic damage and is characterized 
by total inflammatory reactivity of endotheliocytes, 
plasma and cellular factors of blood, connective tissue 
and  on  the  final stages  by  microcirculatory disorders 
in vital organs and tissues [26].  
Thus, blocking the pathological activation of the 
nuclear factor kappa B and preventing the formation 
of vicious circles is a key issue in modern 
pharmacotherapy aimed at timely prevention and 
treatment of interrelated pathology: endothelial 
dysfunction, liver and pancreas diseases. 
 Conclusion. 
Thus, a study of the activity of NF-κB in vitro in 
MNCs of rats with various experimental pathologies 
showed the promise of using Mexidol, ethoxydol, a 
compound with the laboratory cipher XS-9, with an 
anti-inflammatory purpose, which can later be used 
in in vivo studies as well as in cultures of other cells, 
in particular, endotheliocytes. 
Corollaries. 
1. The presented procedure for the evaluation of
the activity of NF-κB is easily reproducible and is 
adequate for the initial screening of drugs – potential 
inhibitors of NF-κB. 
2. The inhibitory activity of 3-hydroxypyridine
compounds is different, but the most active ones are 
mexidol, ethoxydol and XS-9. 
3. In the L-NAME-induced endothelial 
dysfunction, the inhibitory activity of the compounds 
was arranged in the following order: XS-9 → 
ethoxydol → mexidol. 
4. In the case of staphylococcal sepsis and acute
toxic liver damage, the compounds XS-9 and 
ethoxidol showed the same effectiveness with respect 
to the modulation of the activity of the NF-κB 
signaling system, mexidol had the least effect. At the 
same time, on the model of acute toxic liver damage, 
the results of the positive effects of cholesterol-9 and 
ethoxydol significantly differed from mexidol. 
5. On the model of acute pancreatitis the
inhibitory activity of the compounds was arranged in 
the following order: ethoxydol → XS-9 → mexidol. 
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